Form D · Private Equity Fund
LCP Pharma Retail, L.P.
Santiago, F3 · CIK 0002068264
Offering snapshot reported May 22, 2025 · SEC filing
- Reported sold
- Yet to sell Indefinite offering
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 22, 2025 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity, Pooled investment fund
- Exemptions
- 06b, 3C, 3C.7
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-546991
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Fairview Capital Group, Ltd. | None |
Source: Form D, filed May 22, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
The linked fund shows its most recently reported ADV details.
Matched by reported Form D file number
LCP PHARMA RETAIL, L.P.
Investment adviser: TACORA MANAGEMENT COMPANY II LTD.
- Gross asset value
- $140M
- Beneficial owners
- 38
- ADV minimum commitment
- $5M
Reported in Form ADV on Mar 30, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.
Service providers
Provider details
- Annual audit
- Yes
- Prime brokers
- No
- Custodians
- No
- Administrator other than the adviser
- Yes
- External marketing
- No
DELOITTE & TOUCHE LLP
PCAOB 1096
Filing source
Form ADV 2078626 · Mar 30, 2026 · Schedule D 7.B.(1), fund 805-5816753887
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Carlos Ingham | Executive |
| Alfredo Irigoin | Executive |
| N/A Juncal Ltd. | Promoter |
| N/A Linzor Partners Pharma, L.P. | Promoter |
| Timothy Purcell | Executive |
| N/A Tacora Management Company Ii Ltd. | Promoter |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:Santiago, F3, CP 763065